Live feed
Filing
SC 13D/A
SC 13D/A0001193125-17-238884·Inhibitor Therapeutics, Inc.
Schedule 13D ownership disclosure
HedgePath Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 42278K102
Event date: 2015-09-10
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 24.7100%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-17-238884
- Form type
- SC 13D/A
- Filer
- Inhibitor Therapeutics, Inc.
- CIK
- CIK 1042418
- Filed
- Jul 28, 2017
- Reporting period
- Sep 10, 2015
- Description
- Schedule 13D beneficial ownership